SCHEMBL930057

SCHEMBL930057

CCN1C=NC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2327848 0.79 GBA2 (0.31)
SCHEMBL6634969 0.77
SCHEMBL2230207 0.76
SCHEMBL2059958 0.73
SCHEMBL2230812 0.73
SCHEMBL3302565 0.71
Hydrochloric Acid SCHEMBL10805737 0.71
SCHEMBL7796130 0.70
SCHEMBL11405636 0.70
Hydrochloric Acid SCHEMBL8468845 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117915753-A Piezoelectric ion material based on phase separation and intermediate layer interface structure and preparation thereof 东华大学 2024-04-19 CN claimed
EP-2269663-B1 BONE GRAFT AND BIOCOMPOSITE ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2018-03-07 EP claimed
EP-2448609-B1 BONE GRAFT AND BIOCOMPOSITE FOR PROSTHETIC DENTISTRY ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2014-10-08 EP claimed
US-8834935-B2 Bone graft and biocomposite for prosthetic dentistry ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2014-09-16 US claimed
EP-2448609-A2 BONE GRAFT AND BIOCOMPOSITE FOR PROSTHETIC DENTISTRY Armbruster Biotechnology GmbH (DE) 2012-05-09 EP claimed
US-20120107407-A1 BONE GRAFT AND BIOCOMPOSITE FOR PROSTHETIC DENTISTRY ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2012-05-03 US claimed
WO-2011000970-A2 BONE GRAFT AND BIOCOMPOSITE FOR PROSTHETIC DENTISTRY ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2011-01-06 WO claimed
EP-2269663-A2 Bone graft and biocomposite for prosthetic dentistry Armbruster Biotechnology GmbH (DE) 2011-01-05 EP claimed
CN-117915753-A Piezoelectric ion material based on phase separation and intermediate layer interface structure and preparation thereof 东华大学 2024-04-19 CN disclosed
CN-116014240-A Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same 三菱化学株式会社 2023-04-25 CN disclosed
CN-110233290-B Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same 三菱化学株式会社 2023-03-07 CN disclosed
US-10842851-B2 Relaxin for treating patients afflicted of impaired glucose tolerance IMMUNDIAGNOSTIK AG (DE) 2020-11-24 US disclosed
EP-2817026-B1 RELAXIN FOR TREATING IMPAIRED GLUCOSE TOLERANCE AND GLUCOTOXICITY RELAXERA PHARMAZEUTISCHE GMBH & CO KG (DE) 2020-07-15 EP disclosed
EP-2731591-B1 LIPOSOMES CO-ENCAPSULATING A BISPHOSPHONATE AND AN AMPHIPATHIC AGENT YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) 2020-06-17 EP disclosed
US-6545136-B1 Enzyme digestion; wound healing agents; antiulcer agents SEIKAGAKU CORPORATION (JP) 2003-04-08 US disclosed
US-6365733-B1 OLIGOSACCHARIDE PREPARED BY CLEAVING AND DESULFATING KERATIN SULFATE; ANTIINFLAMMATORY AGENTS; ANTICARCINOGENIC AGENTS; ANTIMETASTATIS AGENTS SEIKAGAKU CORPORATION (JP) 2002-04-02 US disclosed
US-6140481-A REACTING SULFATED POLYSACCHARIDE WITH A SPECIFIC SILYLATING AGENT TO SELECTIVELY DESULFATE A SULFATE GROUP BONDED TO THE PRIMARY HYDROXYL GROUP; HEPARIN WITH REDUCED SIDE EFFECTS SEIKAGAKU CORPORATION (JP) 2000-10-31 US disclosed
US-6132994-A Lactosamine oligosaccharides and method for producing the same SEIKAGAKU CORPORATION (JP) 2000-10-17 US disclosed
EP-0926154-A1 NOVEL LACTOSAMINE OLIGOSACCHARIDES AND PROCESS FOR THE PREPARATION THEREOF SEIKAGAKU CORPORATION (JP) 1999-06-30 EP disclosed
EP-0769502-A1 PROCESS FOR PRODUCING DESULFATED POLYSACCHARIDE, AND DESULFATED HEPARIN SEIKAGAKU CORPORATION (JP) 1997-04-23 EP disclosed